AAminove
Back to library

BPC-157

Animal / preclinical

Also known as: Body Protection Compound 157

Healing & recoverySoft-tissue recovery (claimed)Gut health (claimed)

Community-reported ranges are anecdotal and not clinically validated. Evidence grade shown reflects the strength of available human data. Not a prescription. Legal status varies by country and changes over time; verify locally.

Overview

A synthetic peptide fragment popular in recovery circles. Human evidence is essentially absent; the enthusiasm rests on rodent studies and anecdote.

Mechanism

Proposed to promote angiogenesis and modulate growth-factor and nitric-oxide pathways in animal models. Human mechanism is unproven.

Evidence

Animal / preclinicalWhat does this mean?

Thin: promising rodent data but no completed human RCTs establishing efficacy or safety. Treat claims with caution.

Community-reported information

Community discussions report a range of microgram-to-milligram daily amounts. This is anecdotal, unvalidated, and shown as general information only — not advice.

General information only, not tailored to you and not a recommendation. Some regions withhold this entirely.

Half-life

Short (hours); not well characterised in humans.

Storage

Lyophilised: refrigerate. Reconstituted: refrigerate, use within weeks.

Commonly reported side effects

  • Not well characterised in humans
  • Injection-site reactions reported anecdotally

Legal status by region

  • USNot FDA-approved; not a dietary supplement. FDA flagged for compounding restrictions.
  • GBNot licensed for human use; sale for human use restricted.
  • AUSchedule 4 (prescription-only) since June 2024.

Legal status changes over time; verify locally before relying on this.

Citations